Portfolio company
Boomerang Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops bioelectric neuromodulation technology to treat autoimmune diseases, including inflammatory bowel disease, for patients with ulcerative colitis and Crohn's disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Landos Biopharma
This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.
Promakhos Therapeutics
This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.
cAMPfield
The company develops oral biopharmaceutical medicines for patients with immune-mediated inflammatory diseases, specifically focusing on treatments for inflammatory bowel disease.
Gali Health
This digital health company develops a mobile application providing AI-driven disease management support and health tracking for individuals living with inflammatory bowel diseases.
Ensho Therapeutics
This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.
Abivax
This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.
Surf Therapeutics
This company develops non-invasive ultrasound devices to treat patients with chronic inflammatory disorders by stimulating the cholinergic anti-inflammatory pathway.
Setpoint Medical
The company produces implantable vagus nerve stimulation devices to treat adults with chronic autoimmune diseases such as rheumatoid arthritis.
